Stewart & Patten Co. LLC Sells 400 Shares of Aetna (NYSE:AET)

Stewart & Patten Co. LLC lowered its holdings in Aetna (NYSE:AET) by 8.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,400 shares of the company’s stock after selling 400 shares during the period. Stewart & Patten Co. LLC’s holdings in Aetna were worth $744,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Focused Wealth Management Inc increased its position in shares of Aetna by 84.5% in the fourth quarter. Focused Wealth Management Inc now owns 655 shares of the company’s stock worth $118,000 after acquiring an additional 300 shares in the last quarter. Cerebellum GP LLC acquired a new stake in shares of Aetna in the fourth quarter worth $125,000. James Hambro & Partners acquired a new stake in shares of Aetna in the fourth quarter worth $158,000. Harel Insurance Investments & Financial Services Ltd. acquired a new stake in shares of Aetna in the fourth quarter worth $180,000. Finally, Signature Estate & Investment Advisors LLC acquired a new stake in shares of Aetna in the fourth quarter worth $182,000. 87.01% of the stock is owned by institutional investors.

NYSE AET opened at $177.03 on Friday. Aetna has a 12 month low of $176.69 and a 12 month high of $177.56. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.73 and a current ratio of 0.73. The firm has a market cap of $58.05 billion, a price-to-earnings ratio of 17.21, a P/E/G ratio of 1.50 and a beta of 0.64.

Aetna (NYSE:AET) last posted its quarterly earnings data on Tuesday, May 1st. The company reported $3.19 EPS for the quarter, beating the Zacks’ consensus estimate of $2.97 by $0.22. Aetna had a net margin of 5.76% and a return on equity of 21.42%. The firm had revenue of $15.34 billion for the quarter, compared to the consensus estimate of $15.32 billion. During the same period in the prior year, the firm posted $2.71 EPS. The firm’s revenue was up 1.1% compared to the same quarter last year. research analysts expect that Aetna will post 11.06 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 27th. Shareholders of record on Thursday, April 12th were paid a dividend of $0.50 per share. The ex-dividend date was Wednesday, April 11th. This represents a $2.00 dividend on an annualized basis and a yield of 1.13%. Aetna’s dividend payout ratio (DPR) is 20.28%.

A number of research firms recently weighed in on AET. Credit Suisse Group raised their price target on shares of Aetna from $200.00 to $208.00 and gave the company a “neutral” rating in a report on Wednesday, January 31st. Citigroup lowered shares of Aetna from a “buy” rating to a “neutral” rating and raised their price target for the company from $187.89 to $212.00 in a report on Wednesday, January 31st. Cowen reaffirmed a “buy” rating and set a $212.00 price target on shares of Aetna in a report on Tuesday, January 30th. Piper Jaffray reaffirmed a “buy” rating and set a $212.00 price target on shares of Aetna in a report on Tuesday, January 30th. Finally, Deutsche Bank raised shares of Aetna from a “hold” rating to a “buy” rating and raised their price target for the company from $195.00 to $212.00 in a report on Monday, January 22nd. Eight analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $196.36.

Aetna Company Profile

Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply